Go Pro

The Manufacturers Life Insurance Company Invests $901,000 in Addus HomeCare Corporation $ADUS

Addus HomeCare logo with Healthcare background
Image from MarketBeat Media, LLC.

The Manufacturers Life Insurance Company bought a new stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 8,963 shares of the company's stock, valued at approximately $901,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. BlackRock Inc. bought a new position in shares of Addus HomeCare in the second quarter worth approximately $344,153,000. Capital Research Global Investors raised its holdings in Addus HomeCare by 22.3% during the 4th quarter. Capital Research Global Investors now owns 1,469,752 shares of the company's stock valued at $157,837,000 after buying an additional 268,192 shares during the last quarter. Vanguard Group Inc. raised its holdings in Addus HomeCare by 0.8% during the 4th quarter. Vanguard Group Inc. now owns 1,308,605 shares of the company's stock valued at $140,531,000 after buying an additional 10,501 shares during the last quarter. Wasatch Advisors LP boosted its position in Addus HomeCare by 0.8% during the 3rd quarter. Wasatch Advisors LP now owns 936,243 shares of the company's stock valued at $110,467,000 after buying an additional 7,089 shares during the period. Finally, Dimensional Fund Advisors LP boosted its position in Addus HomeCare by 11.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 744,127 shares of the company's stock valued at $69,689,000 after buying an additional 78,415 shares during the period. 95.35% of the stock is currently owned by institutional investors.

Addus HomeCare Price Performance

ADUS stock opened at $118.76 on Friday. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.69 and a quick ratio of 1.69. Addus HomeCare Corporation has a 1 year low of $87.95 and a 1 year high of $124.43. The firm has a 50-day moving average of $114.01 and a 200 day moving average of $103.20. The company has a market cap of $2.22 billion, a P/E ratio of 20.84, a PEG ratio of 1.59 and a beta of 0.86.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings data on Monday, August 3rd. The company reported $1.73 earnings per share for the quarter, beating the consensus estimate of $1.70 by $0.03. Addus HomeCare had a return on equity of 9.96% and a net margin of 7.13%.The business had revenue of $377.41 million for the quarter, compared to analysts' expectations of $376.24 million. During the same period in the previous year, the firm posted $1.49 EPS. The business's revenue was up 8.0% on a year-over-year basis. On average, sell-side analysts forecast that Addus HomeCare Corporation will post 6.3 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts have issued reports on ADUS shares. Barclays boosted their price objective on shares of Addus HomeCare from $92.00 to $96.00 and gave the company an "underweight" rating in a research report on Wednesday, July 8th. Citizens Jmp reiterated a "market outperform" rating and set a $142.00 target price on shares of Addus HomeCare in a report on Monday, May 18th. Citigroup reissued a "market outperform" rating on shares of Addus HomeCare in a research note on Friday, July 24th. Weiss Ratings upgraded Addus HomeCare from a "hold (c-)" rating to a "hold (c)" rating in a report on Thursday, July 9th. Finally, Royal Bank Of Canada boosted their target price on Addus HomeCare from $130.00 to $134.00 and gave the company an "outperform" rating in a research note on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $128.86.

Check Out Our Latest Stock Report on Addus HomeCare

Insider Activity at Addus HomeCare

In related news, insider Heather Dixon sold 288 shares of Addus HomeCare stock in a transaction that occurred on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total transaction of $27,005.76. Following the sale, the insider directly owned 44,371 shares in the company, valued at $4,160,668.67. The trade was a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.10% of the stock is currently owned by insiders.

Addus HomeCare Company Profile

(Free Report)

Addus HomeCare NASDAQ: ADUS is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients' independence and quality of life.

The company's core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

Read More

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines